Mark L Schultz - Publications

Affiliations: 
University of Michigan, Ann Arbor, Ann Arbor, MI 
Area:
Lysosome, Lysosomal Storage Diseases, Neuroscience, Cell Biology

15 high-probability publications. We are testing a new system for linking publications to authors. You can help! If you notice any inaccuracies, please sign in and mark papers as correct or incorrect matches. If you identify any major omissions or other inaccuracies in the publication list, please let us know.

Year Citation  Score
2023 Halseth TA, Correia AB, Schultz ML, Fawaz MV, Kuiper EQ, Kumaran P, Dorsey KH, Schuchman EH, Lieberman AP, Schwendeman A. Apolipoprotein-mimetic nanodiscs reduce lipid accumulation and improve liver function in acid sphingomyelinase deficiency. Nanomedicine : Nanotechnology, Biology, and Medicine. 102705. PMID 37633404 DOI: 10.1016/j.nano.2023.102705  0.621
2022 Schultz ML, Schache KJ, Azaria RD, Kuiper EQ, Erwood S, Ivakine EA, Farhat NY, Porter FD, Pathmasiri KC, Cologna SM, Uhler MD, Lieberman AP. Species-specific differences in NPC1 protein trafficking govern therapeutic response in Niemann-Pick type C disease. Jci Insight. PMID 36301667 DOI: 10.1172/jci.insight.160308  0.791
2022 Deng L, Mojica-Perez SP, Azaria RD, Schultz M, Parent JM, Niu W. Loss of POGZ alters neural differentiation of human embryonic stem cells. Molecular and Cellular Neurosciences. 120: 103727. PMID 35367590 DOI: 10.1016/j.mcn.2022.103727  0.753
2021 Ilnytska O, Lai K, Gorshkov K, Schultz ML, Tran BN, Jeziorek M, Kunkel TJ, Azaria RD, McLoughlin HS, Waghalter M, Xu Y, Schlame M, Altan-Bonnet N, Zheng W, Lieberman AP, et al. Enrichment of NPC1-deficient cells with the lipid LBPA stimulates autophagy, improves lysosomal function, and reduces cholesterol storage. The Journal of Biological Chemistry. 100813. PMID 34023384 DOI: 10.1016/j.jbc.2021.100813  0.704
2020 Liu EA, Schultz ML, Mochida C, Chung C, Paulson HL, Lieberman AP. Fbxo2 mediates clearance of damaged lysosomes and modifies neurodegeneration in the Niemann-Pick C brain. Jci Insight. PMID 32931479 DOI: 10.1172/Jci.Insight.136676  0.686
2019 Schultz ML, Fawaz MV, Azaria RD, Hollon TC, Liu EA, Kunkel TJ, Halseth TA, Krus KL, Ming R, Morin EE, McLoughlin HS, Bushart DD, Paulson HL, Shakkottai VG, Orringer DA, et al. Synthetic high-density lipoprotein nanoparticles for the treatment of Niemann-Pick diseases. Bmc Medicine. 17: 200. PMID 31711490 DOI: 10.1186/S12916-019-1423-5  0.619
2018 Schultz ML, Krus KL, Kaushik S, Dang D, Chopra R, Qi L, Shakkottai VG, Cuervo AM, Lieberman AP. Coordinate regulation of mutant NPC1 degradation by selective ER autophagy and MARCH6-dependent ERAD. Nature Communications. 9: 3671. PMID 30202070 DOI: 10.1038/S41467-018-06115-2  0.763
2018 Schultz ML, Tecedor L, Lysenko E, Ramachandran S, Stein CS, Davidson BL. Modulating membrane fluidity corrects Batten disease phenotypes in vitro and in vivo. Neurobiology of Disease. PMID 29660499 DOI: 10.1016/J.Nbd.2018.04.010  0.595
2018 Gurda BL, Bagel JH, Fisher SJ, Schultz ML, Lieberman AP, Hand P, Vite CH, Swain GP. LC3 Immunostaining in the Inferior Olivary Nuclei of Cats With Niemann-Pick Disease Type C1 Is Associated With Patterned Purkinje Cell Loss. Journal of Neuropathology and Experimental Neurology. PMID 29346563 DOI: 10.1093/Jnen/Nlx119  0.666
2018 Fawaz MV, Schultz M, Azaria R, Ming R, Lieberman A, Schwendeman A. Abstract 164: Synthetic High-Density Lipoprotein Cholesterol Scavengers for the Treatment of Niemann-Pick C Disease Arteriosclerosis, Thrombosis, and Vascular Biology. 38. DOI: 10.1161/Atvb.38.Suppl_1.164  0.796
2017 Ahrens-Nicklas RC, Tecedor L, Schultz ML, Lysenko E, Ramachandran S, Marsh ED, Davidson BL. Small molecule therapies for juvenile neuronal ceroid lipofuscinosis Molecular Genetics and Metabolism. 120: S18-S19. DOI: 10.1016/J.Ymgme.2016.11.015  0.436
2016 Schultz ML, Krus KL, Lieberman AP. Lysosome and endoplasmic reticulum quality control pathways in Niemann-pick type C disease. Brain Research. PMID 27026653 DOI: 10.1016/J.Brainres.2016.03.035  0.78
2014 Schultz ML, Tecedor L, Stein CS, Stamnes MA, Davidson BL. CLN3 deficient cells display defects in the ARF1-Cdc42 pathway and actin-dependent events. Plos One. 9: e96647. PMID 24792215 DOI: 10.1371/Journal.Pone.0096647  0.564
2013 Tecedor L, Stein CS, Schultz ML, Farwanah H, Sandhoff K, Davidson BL. CLN3 loss disturbs membrane microdomain properties and protein transport in brain endothelial cells. The Journal of Neuroscience : the Official Journal of the Society For Neuroscience. 33: 18065-79. PMID 24227717 DOI: 10.1523/Jneurosci.0498-13.2013  0.546
2011 Schultz ML, Tecedor L, Chang M, Davidson BL. Clarifying lysosomal storage diseases. Trends in Neurosciences. 34: 401-10. PMID 21723623 DOI: 10.1016/J.Tins.2011.05.006  0.592
Show low-probability matches.